A bitter pill to swallow

Article Abstract:

Bristol Myers Squibb has withdrawn its new hypertension treatment, Vanlev, and delayed its launch for 12 months because of its possible rejection by the US Food and Drug Administration. Meanwhile, in the chemicals sector, antitrust concerns of the US Federal Trade Commission have negatively impacted Air Liquide and Air Products takeover of BOC.

Health aspects, Pharmaceutical industry, Product information, Powers and duties, Bristol-Myers Squibb Co., BMY, Air Products and Chemicals Inc., APD, United States. Food and Drug Administration, Antihypertensive drugs, Antihypertensive agents, Air Liquide, BOC Group Inc.

---

Cinven buys Burmah Castrol

Article Abstract:

Issues are presented concerning the successful acquisition of BP's chemical subsidiary Burmah Castrol by the private equity business enterprise Cinven for 204-million pounds sterling. Acquisition activity in the chemical sector is discussed.

Economic aspects, Acquisitions and mergers, Burmah-Castrol Inc., Cinven (UK)

---

French domestic chemistry takes off

Article Abstract:

Consolidation is still occurring in France's chemicals industry in 2001 despite a slowdown in European mergers and acquisitions. A report on deals in the sector in March 2001 is presented.

France

Similar abstracts:

• Abstracts: Africa: international economy. North America. North America: International economy
• Abstracts: Super Mario. Pedro Solbes, commissioner for the euro. From boom to boom
• Abstracts: A tussle over tax. New Europe, new America. Data dogfights
• Abstracts: Welcome to Europe. Europe's mid-life crisis. Eventually supreme?
• Abstracts: How poor is India? The rich get richer. Indian poverty and the numbers game

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.